{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T04:06:22Z","timestamp":1782273982456,"version":"3.54.5"},"reference-count":51,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1097\/fpc.0000000000000313","type":"journal-article","created":{"date-parts":[[2017,10,31]],"date-time":"2017-10-31T17:21:35Z","timestamp":1509470495000},"page":"464-472","source":"Crossref","is-referenced-by-count":13,"title":["Influence of polygenic risk scores on lipid levels and dyslipidemia in a psychiatric population receiving weight gain-inducing psychotropic drugs"],"prefix":"10.1097","volume":"27","author":[{"given":"Aur\u00e9lie","family":"Delacr\u00e9taz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Lagares Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Saigi Morgui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik","family":"Vandenberghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana\u00efs","family":"Glatard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Gholam-Rezaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"von Gunten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Conus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin B.","family":"Eap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210213","doi-asserted-by":"crossref","first-page":"227","DOI":"10.5001\/omj.2015.47","article-title":"Non-communicable diseases: shining a light on cardiovascular disease, Oman\u2019s biggest killer","volume":"30","author":"Al-Mawali","year":"2015","journal-title":"Oman Med J"},{"key":"R2-5-20210213","doi-asserted-by":"crossref","first-page":"e442","DOI":"10.1371\/journal.pmed.0030442","article-title":"Projections of global mortality and burden of disease from 2002 to 2030","volume":"3","author":"Mathers","year":"2006","journal-title":"PLoS Med"},{"key":"R3-5-20210213","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s12170-010-0131-7","article-title":"Clinical implications of lipid genetics for cardiovascular disease","volume":"4","author":"Strong","year":"2010","journal-title":"Curr Cardiovasc Risk Rep"},{"key":"R4-5-20210213","doi-asserted-by":"crossref","first-page":"969","DOI":"10.4103\/2230-8210.122600","article-title":"Atherogenic dyslipidemia","volume":"17","author":"Manjunath","year":"2013","journal-title":"Indian J Endocrinol Metab"},{"key":"R5-5-20210213","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/clc.4960171003","article-title":"Dyslipidemia and coronary artery disease","volume":"17","author":"Kuo","year":"1994","journal-title":"Clin Cardiol"},{"key":"R6-5-20210213","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1191\/1358863x02vm453ra","article-title":"Undertreatment of dyslipidemia in peripheral arterial disease and other high-risk populations: an opportunity for cardiovascular disease reduction","volume":"7","author":"Hirsch","year":"2002","journal-title":"Vasc Med"},{"key":"R7-5-20210213","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1139\/o03-085","article-title":"Lipids and atherosclerosis","volume":"82","author":"Choy","year":"2004","journal-title":"Biochem Cell Biol"},{"key":"R8-5-20210213","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s11886-012-0313-7","article-title":"Dyslipidemias in the prevention of cardiovascular disease: risks and causality","volume":"14","author":"Graham","year":"2012","journal-title":"Curr Cardiol Rep"},{"key":"R9-5-20210213","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cca.2015.10.033","article-title":"Update on the molecular biology of dyslipidemias","volume":"454","author":"Ramasamy","year":"2016","journal-title":"Clin Chim Acta"},{"key":"R10-5-20210213","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1524-6175.2006.04751.x","article-title":"Drug-induced metabolic syndrome","volume":"8","author":"Wofford","year":"2006","journal-title":"J Clin Hypertens"},{"key":"R11-5-20210213","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/wps.20204","article-title":"Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder","volume":"14","author":"Correll","year":"2015","journal-title":"World Psychiatry"},{"key":"R12-5-20210213","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1001\/jamapsychiatry.2014.1314","article-title":"Cardiometabolic risk in patients with first-episode schizophrenia spectrum disorders: baseline results from the RAISE-ETP study","volume":"71","author":"Correll","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"R13-5-20210213","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/nrendo.2011.156","article-title":"Metabolic and cardiovascular adverse effects associated with antipsychotic drugs","volume":"8","author":"De Hert","year":"2012","journal-title":"Nat Rev Endocrinol"},{"key":"R14-5-20210213","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00213-011-2211-x","article-title":"Association of genetic variants of the histamine H1 and muscarinic M3 receptors with BMI and HbA1c values in patients on antipsychotic medication","volume":"216","author":"Vehof","year":"2011","journal-title":"Psychopharmacology (Berl"},{"key":"R15-5-20210213","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1001\/jamapsychiatry.2013.187","article-title":"Influence of CRTC1 polymorphisms on body mass index and fat mass in psychiatric patients and the general adult population","volume":"70","author":"Choong","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"R16-5-20210213","doi-asserted-by":"crossref","first-page":"e0139155","DOI":"10.1371\/journal.pone.0139155","article-title":"Influence of MCHR2 and MCHR2-AS1 genetic polymorphisms on body mass index in psychiatric patients and in population-based subjects with present or past atypical depression","volume":"10","author":"Delacretaz","year":"2015","journal-title":"PloS One"},{"key":"R17-5-20210213","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/clpt.2011.97","article-title":"Mechanisms and genetics of antipsychotic-associated weight gain","volume":"90","author":"Balt","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"R18-5-20210213","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/mp.2011.109","article-title":"Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications","volume":"17","author":"Lett","year":"2012","journal-title":"Mol Psychiatry"},{"key":"R19-5-20210213","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/1359786806066040","article-title":"The 5-HT2C receptor and antipsychoticinduced weight gain \u2013 mechanisms and genetics","volume":"20","author":"Reynolds","year":"2006","journal-title":"J Psychopharmacol"},{"key":"R20-5-20210213","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1073\/pnas.0611417104","article-title":"From the Cover: Antipsychotic drug-induced weight gain mediated by histamine H1 receptor-linked activation of hypothalamic AMP-kinase","volume":"104","author":"Kim","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"R21-5-20210213","doi-asserted-by":"crossref","first-page":"e661","DOI":"10.1038\/tp.2015.161","article-title":"A potential mechanism underlying atypical antipsychotics-induced lipid disturbances","volume":"5","author":"Cai","year":"2015","journal-title":"Transl Psychiatry"},{"key":"R22-5-20210213","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00210-010-0499-4","article-title":"Antipsychotic drug action on SREBPs-related lipogenesis and cholesterogenesis in primary rat hepatocytes","volume":"381","author":"Lauressergues","year":"2010","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"R23-5-20210213","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/sj.tpj.6500323","article-title":"Antipsychotic drugs activate SREBP-regulated expression of lipid biosynthetic genes in cultured human glioma cells: a novel mechanism of action?","volume":"5","author":"Ferno","year":"2005","journal-title":"Pharmacogenomics J"},{"key":"R24-5-20210213","doi-asserted-by":"crossref","first-page":"e18939","DOI":"10.1371\/journal.pone.0018939","article-title":"A genome-wide association study on obesity and obesity-related traits","volume":"6","author":"Wang","year":"2011","journal-title":"PloS One"},{"key":"R25-5-20210213","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/ije\/dyv077","article-title":"A genome-wide association study of body mass index across early life and childhood","volume":"44","author":"Warrington","year":"2015","journal-title":"Int J Epidemiol"},{"key":"R26-5-20210213","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nature14177","article-title":"Genetic studies of body mass index yield new insights for obesity biology","volume":"518","author":"Locke","year":"2015","journal-title":"Nature"},{"key":"R27-5-20210213","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/ng.3300","article-title":"The impact of low-frequency and rare variants on lipid levels","volume":"47","author":"Surakka","year":"2015","journal-title":"Nat Genet"},{"key":"R28-5-20210213","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/ng.2797","article-title":"Discovery and refinement of loci associated with lipid levels","volume":"45","author":"Global Lipids Genetics","year":"2013","journal-title":"Nat Genet"},{"key":"R29-5-20210213","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/19485565.2013.774628","article-title":"Development and evaluation of a genetic risk score for obesity","volume":"59","author":"Belsky","year":"2013","journal-title":"Biodemography Soc Biol"},{"key":"R30-5-20210213","doi-asserted-by":"crossref","first-page":"e0146081","DOI":"10.1371\/journal.pone.0146081","article-title":"The combined effect of common genetic risk variants on circulating lipoproteins is evident in childhood: a longitudinal analysis of the Cardiovascular Risk in Young Finns Study","volume":"11","author":"Buscot","year":"2016","journal-title":"PloS One"},{"key":"R31-5-20210213","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12916-015-0334-3","article-title":"A genetic risk score combining 32 SNPs is associated with body mass index and improves obesity prediction in people with major depressive disorder","volume":"13","author":"Hung","year":"2015","journal-title":"BMC Med"},{"key":"R32-5-20210213","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1007\/s00125-008-1254-y","article-title":"Risk prediction of prevalent diabetes in a Swiss population using a weighted genetic score \u2013 the CoLaus Study","volume":"52","author":"Lin","year":"2009","journal-title":"Diabetologia"},{"key":"R33-5-20210213","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/FPC.0000000000000210","article-title":"Association of genetic risk scores with body mass index in Swiss psychiatric cohorts","volume":"26","author":"Saigi-Morgui","year":"2016","journal-title":"Pharmacogenet Genomics"},{"key":"R35-5-20210213","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/01.hjh.0000431740.32696.cc","article-title":"2013 ESH\/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"31","author":"Mancia","year":"2013","journal-title":"J Hypertens"},{"key":"R37-5-20210213","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/YIC.0000000000000014","article-title":"Pharmacological treatment of antipsychotic-induced dyslipidemia and hypertension","volume":"29","author":"Tse","year":"2014","journal-title":"Int Clin Psychopharmacol"},{"key":"R38-5-20210213","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1471-2105-12-77","article-title":"pROC: an open-source package for R and S+ to analyze and compare ROC curves","volume":"12","author":"Robin","year":"2011","journal-title":"BMC bioinformatics"},{"key":"R39-5-20210213","first-page":"145","article-title":"A clinical approach to pharmacogenetics","volume":"71","author":"De Graaff","year":"2013","journal-title":"Neth J Med"},{"key":"R40-5-20210213","first-page":"1994","article-title":"Follow-up of the metabolic syndrome induced by atypical antipsychotics: recommendations and pharmacogenetics perspectives","volume":"4","author":"Choong","year":"2008","journal-title":"Rev Med Suisse"},{"key":"R41-5-20210213","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.","volume":"106","year":"2002","journal-title":"Circulation"},{"key":"R42-5-20210213","doi-asserted-by":"crossref","first-page":"e1417","DOI":"10.4088\/JCP.14m09358","article-title":"Importance of early weight changes to predict long-term weight gain during psychotropic drug treatment","volume":"76","author":"Vandenberghe","year":"2015","journal-title":"J Clin Psychiatry"},{"key":"R43-5-20210213","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1161\/CIRCGENETICS.114.000637","article-title":"Interactions of lipid genetic risk scores with estimates of metabolic health in a Danish population","volume":"8","author":"Justesen","year":"2015","journal-title":"Circ Cardiovasc Genet"},{"key":"R44-5-20210213","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jad.2016.03.031","article-title":"Association of CRTC1 polymorphisms with obesity markers in subjects from the general population with lifetime depression","volume":"198","author":"Quteineh","year":"2016","journal-title":"J Affect Disord"},{"key":"R45-5-20210213","doi-asserted-by":"crossref","first-page":"152","DOI":"10.4088\/PCC.v06n0402","article-title":"The metabolic syndrome in patients with severe mental illnesses","volume":"6","author":"Toalson","year":"2004","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"R46-5-20210213","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000445802","article-title":"Genetics of common antipsychotic-induced adverse effects","volume":"2","author":"MacNeil","year":"2016","journal-title":"Mol Neuropsychiatry"},{"key":"R47-5-20210213","doi-asserted-by":"crossref","first-page":"477","DOI":"10.2217\/pgs.13.220","article-title":"Association of FTO, LEPR and MTHFR gene polymorphisms with metabolic syndrome in schizophrenia patients receiving antipsychotics","volume":"15","author":"Roffeei","year":"2014","journal-title":"Pharmacogenomics"},{"key":"R48-5-20210213","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/ng.3561","article-title":"Variants with large effects on blood lipids and the role of cholesterol and triglycerides in coronary disease","volume":"48","author":"Helgadottir","year":"2016","journal-title":"Nat Genet"},{"key":"R49-5-20210213","doi-asserted-by":"crossref","first-page":"i2416","DOI":"10.1136\/bmj.i2416","article-title":"Prediction models for cardiovascular disease risk in the general population: systematic review","volume":"353","author":"Damen","year":"2016","journal-title":"BMJ"},{"key":"R50-5-20210213","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1161\/CIRCGENETICS.111.961342","article-title":"A genetic risk score is associated with incident cardiovascular disease and coronary artery calcium: the Framingham Heart Study","volume":"5","author":"Thanassoulis","year":"2012","journal-title":"Circ Cardiovasc Genet"},{"key":"R51-5-20210213","doi-asserted-by":"crossref","first-page":"e43834","DOI":"10.1371\/journal.pone.0043834","article-title":"Development and evaluation of a simple and effective prediction approach for identifying those at high risk of dyslipidemia in rural adult residents","volume":"7","author":"Wang","year":"2012","journal-title":"PloS One"},{"key":"R52-5-20210213","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/GIM.0b013e31812eece0","article-title":"The impact of genotype frequencies on the clinical validity of genomic profiling for predicting common chronic diseases","volume":"9","author":"Janssens","year":"2007","journal-title":"Genet Med"},{"key":"R53-5-20210213","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00439-016-1636-z","article-title":"Improved prediction of complex diseases by common genetic markers: state of the art and further perspectives","volume":"135","author":"Muller","year":"2016","journal-title":"Hum Genet"}],"container-title":["Pharmacogenetics and Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FPC.0000000000000313","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:24:09Z","timestamp":1620951849000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01213011-201712000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":51,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/fpc.0000000000000313","relation":{},"ISSN":["1744-6872"],"issn-type":[{"value":"1744-6872","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]}}}